Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,551.01
(
-0.09%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 221425

Tuesday, 10/16/2018 7:07:08 PM

Tuesday, October 16, 2018 7:07:08 PM

Post# of 257443
Re: ENTA's HBV data (ASMB)

On the two slides you referenced (#33-34 from ENTA's latest slide set), I interpret the blank EC50 entries for other companies' HBV candidates to mean that ENTA does not have data available to enter a value. I.e., I do not interpret the blank entries to mean that the other companies' candidates lack activity in the cell line or HBV genotype in question.

If anyone disagrees with the above interpretation, or has other comments on mcbio's post, please reply!

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today